---

---

tags : Covid    symbols : Fnctf   

save search

---

BioLink Life Sciences, Charak Foundation and KARE Biosciences Announce contract for developing a novel treatment of COVID pneumonia and prevention of long COVID
Published: 2022-10-05 (Crawled : 22:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| 21.67% | O: 4.3% H: 0.0% C: -9.09%
treatment covid life contract

---

The REMM Group Designs Their New Orange County Corporate Headquarters for the Post COVID Work Style
Published: 2022-05-24 (Crawled : 20:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
covid work group designation

---

Citrus Phytochemicals & Long COVID Recovery Study
Published: 2022-04-14 (Crawled : 17:00) - limoneira.com
LMNR 4 | $19.57 1.29% 1.28% 53K |

Process Industries

| 42.47% | O: 0.22% H: 2.03% C: 0.51%
covid citrus

---

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
Published: 2022-03-15 (Crawled : 23:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -50.2% | O: 0.56% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -9.99% | O: 0.82% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -40.15% | O: 1.63% H: 11.55% C: 11.21%
covid-19 covid authorization vaccine tiona merge order emergency use authorization

---

Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States
Published: 2022-02-08 (Crawled : 12:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M |

Health Technology

| 59.64% | O: -2.14% H: 0.3% C: -0.25%
covid-19 state covid molnupiravir antiviral

---

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies
Published: 2022-01-28 (Crawled : 12:30) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M |

Health Technology

| 56.09% | O: -1.29% H: 1.82% C: 1.71%
covid-19 covid molnupiravir antiviral in vitro

---

Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine
Published: 2022-01-18 (Crawled : 13:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| -2.34% | O: -0.4% H: 0.0% C: -0.58%
MRK | News | $125.78 0.44% 0.0% 8.4M |

Health Technology

| 54.4% | O: -0.37% H: 0.0% C: 0.0%
covid-19 covid molnupiravir antiviral

---

Beyond COVID-19: the Potential of mRNA in Occupational Cancer
Published: 2022-01-13 (Crawled : 13:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
covid-19 covid potential cancer

---

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and Older
Published: 2022-01-03 (Crawled : 18:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -6.36% | O: -0.47% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -55.97% | O: -0.93% H: 0.09% C: -3.16%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -7.58% | O: 1.16% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -66.33% | O: -1.52% H: 0.89% C: -8.67%
covid-19 fda als covid authorization vaccine merge order emergency use authorization

---

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval for Emergency in Japan
Published: 2021-12-24 (Crawled : 14:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M |

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
covid-19 treatment approval covid molnupiravir antiviral merge

---

Top DevOps Services and Popular Tools at GoodFirms Assist Businesses in Faster Software Development Cycle During Covid-19
Published: 2021-12-14 (Crawled : 09:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| 7.14% | O: 1.65% H: 0.0% C: -1.39%
covid-19 covid software

---

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older
Published: 2021-12-09 (Crawled : 18:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| 8.08% | O: 0.69% H: 0.68% C: 0.68%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -49.42% | O: 0.23% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -3.88% | O: -0.85% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -71.9% | O: -3.53% H: 0.32% C: -4.65%
covid-19 fda covid authorization vaccine merge order emergency use authorization

---

Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age
Published: 2021-11-22 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -8.6% | O: -0.92% H: 0.0% C: -0.23%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -49.85% | O: -1.72% H: 1.02% C: 0.49%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -8.08% | O: -0.89% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -68.82% | O: 7.04% H: 8.12% C: 7.96%
covid vaccine phase 3 trial

---

Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older
Published: 2021-11-19 (Crawled : 13:30) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| -1.65% | O: -2.67% H: 0.45% C: 0.45%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -5.6% | O: 3.28% H: 0.0% C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -49.43% | O: 0.84% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -7.71% | O: 0.4% H: 0.0% C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| -68.32% | O: 1.58% H: 0.0% C: 0.0%
covid fda vaccine merge order emergency use authorization

---

Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Published: 2021-10-29 (Crawled : 22:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
BNTX | $86.82 0.75% 0.75% 1.6M |

Health Technology

| Email alert Add to watchlist
covid fda children vaccine merge emergency use authorization

---

OBHealthy and Dr. Ernest Rogers Creates Webinar to Address COVID-19 Concerns for Pets
Published: 2021-09-10 (Crawled : 13:00) - prnewswire.com
FNCTF | News | $11.0354 -20.84% 320 |

Communications

| Email alert Add to watchlist
covid pets covid-19

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---